Belviq Lawsuit in Louisiana

Doctors prescribe Belviq, also known as lorcaserin, to people who struggle with weight management. Unfortunately, Belviq has been linked to several types of cancer, and the Food and Drug Administration requested that Eisai Co., the drug’s manufacturer, remove Belviq and Belviq XR from the market.

Dudley DeBosier is now accepting inquiries from people who took Belviq and have been diagnosed with cancer. We believe that negligent drug manufacturers should be held responsible for the harm their products have caused.

If you or a loved one wants to discuss a Belviq lawsuit, contact the Louisiana drug injury attorneys at Dudley DeBosier today for a free consultation.

The FDA first approved Belviq (lorcaserin) in 2012. The drug was made available to consumers in 2013. The FDA continued clinical trials out of concern for cardiovascular health risks associated with the medication, but the trials revealed a link to cancer. Though several types of increased cancer risks have been linked to lorcaserin, the three most likely are pancreatic, colorectal, and lung cancers.

Federal regulators believe that the risks of taking Belviq outweigh the benefits. Though Eisai said they disagree with the FDA’s assertion, they’ve complied with FDA’s request to remove the drug from the market. Meanwhile, seven years passed between the drug’s release and the recall of lorcaserin due to cancer risks.

It’s tragic that a drug with links to cancer has been widely available for so long, but it’s a common story in our healthcare system. Users of Belviq deserve answers from Eisai, and the company should be held responsible for the costs now facing people who suffered dearly for trusting in this drug to help them manage their weight.

Common Signs of These Types of Cancer

If you’ve taken Belviq and are concerned about your health, you should be aware of the signs of three types of cancer linked to this medication.

Signs of pancreatic cancer

Pancreatic cancer often causes few to no symptoms early on. It’s only when it’s advanced that people experience:

  • Jaundice
  • Stomach pain
  • Back pain
  • Nausea
  • Weight loss
  • Blood clots

Signs of colorectal cancer

  • Disruptions to regular bowel movement habits
  • Blood in stool
  • Chronic cramps
  • Chronic gas
  • Excessive fatigue
  • Weight loss

Signs of lung cancer

  • Chest pain
  • Excessive, chronic cough
  • Blood from coughing
  • Breathing difficulties
  • Fatigue
  • Persistent bronchitis or colds
  • Weight loss

If you are experiencing any signs of these cancers, see a doctor immediately. If Belviq contributed to your condition, you deserve compensation for the damages you’re experiencing.

If you’re considering taking legal action related to Belviq, contact the Louisiana drug injury lawyers at Dudley DeBosier to schedule a free consultation. We know how important these cases are for people who suffer needlessly because of a drug manufacturer’s negligence.

Contact our team today to schedule a free, no-obligation case assessment. We’re here to help.